oxatomide and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

oxatomide has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tschopp, JM; Turner-Warwick, M1
Charlton, J; D'Souza, MF; Emanuel, MB; Goldschmidt, J; Gregg, J1

Trials

1 trial(s) available for oxatomide and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
A method for evaluating therapy for hay fever. A comparison of four treatments.
    Clinical allergy, 1983, Volume: 13, Issue:4

    Topics: Adult; Airway Resistance; Beclomethasone; Clinical Trials as Topic; Cromolyn Sodium; Female; Forced Expiratory Volume; Humans; Male; Patient Compliance; Piperazines; Placebos; Pollen; Rhinitis, Allergic, Seasonal; Self-Assessment

1983

Other Studies

1 other study(ies) available for oxatomide and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Persisting airflow limitation in asthmatics receiving routine self-adjusted medication.
    European journal of respiratory diseases, 1984, Volume: 65, Issue:5

    Topics: Adult; Aerosols; Age Factors; Albuterol; Asthma; Beclomethasone; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Piperazines; Pulmonary Ventilation; Respiratory Therapy; Spirometry; Time Factors

1984